Of 21 peptides, three peptides frequently induced specific T cell responses in PBMCs obtained from either healthy subjects or cancer patients, and these peptide-specific T cells also recognized HLA-A2+ PSGR-expressing LNCaP cells, suggesting that these peptides are naturally processed by prostate cancer cells. The gene discussed is OR51E2; the disease is prostate cancer.